Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.
Research Interests

Papers共 21 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
Philippe Damier, Bertrand Degos, Giovanni Castelonovo,Mathieu Anheim,Isabelle Benatru,Nicolas Carrière,Olivier Colin,Luc Defebvre, Marie Deverdal,Alexandre Eusebio, Vanessa Ferrier,Caroline Giordana,
Movement disorders : official journal of the Movement Disorder Societyno. 3 (2024): 618-622
Cited0Views0WOSBibtex
0
0
TMEM151A as an alternative to PRRT2 in paroxysmal kinesigenic dyskinesia: About three new cases
Othman Mounir Alaoui, Pierre-François Charbonneau, Pauline Prin,Marie Mongin, Mathilde Choquer,Philippe Damier,Florence Riant, Bertrand Degos
Parkinsonism & related disorders (2023): 105295-105295
Cited0Views0WOSBibtex
0
0
Clinical and Radiological Follow-Up of a Pfizer-BioNTech COVID-19 Vaccine-Induced Hemichorea-Hemiballismus
Cedric Batot,Maryane Chea,Sinead Zeidan,Marie Mongin, Gabriel Pop,Julie Mazoyer, Bertrand Degos
TREMOR AND OTHER HYPERKINETIC MOVEMENTSno. 1 (2022): 1-6
Cited6Views0WOSBibtex
6
0
Hémichorée-hémiballisme post-vaccination Covid-19 : à propos d’un cas
Maryane Chea, Bertrand Degos, Cédric Batot,Sinéad Zeidan,Julie Mazoyer, Gabriel Pop,Marie Mongin
Revue Neurologique (2022): S28-S28
Cited0Views0Bibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn